BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37012245)

  • 21. Use of heparin to rescue immunosuppressive monocyte reprogramming by glioblastoma-derived extracellular vesicles.
    Himes BT; Fain CE; Tritz ZP; Nesvick CL; Jin-Lee HJ; Geiger PA; Peterson TE; Jung MY; Parney IF
    J Neurosurg; 2023 May; 138(5):1291-1301. PubMed ID: 36115048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma.
    Nakazawa T; Morimoto T; Maeoka R; Matsuda R; Nakamura M; Nishimura F; Ouji N; Yamada S; Nakagawa I; Park YS; Ito T; Nakase H; Tsujimura T
    J Exp Clin Cancer Res; 2023 Aug; 42(1):205. PubMed ID: 37563692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.
    Song CQ; Li Y; Mou H; Moore J; Park A; Pomyen Y; Hough S; Kennedy Z; Fischer A; Yin H; Anderson DG; Conte D; Zender L; Wang XW; Thorgeirsson S; Weng Z; Xue W
    Gastroenterology; 2017 Apr; 152(5):1161-1173.e1. PubMed ID: 27956228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
    Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
    Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
    Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G
    J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
    Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
    J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes.
    Mattoscio D; Isopi E; Lamolinara A; Patruno S; Medda A; De Cecco F; Chiocca S; Iezzi M; Romano M; Recchiuti A
    J Exp Clin Cancer Res; 2021 Apr; 40(1):129. PubMed ID: 33845864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of VEGF blockade on the dynamics of the inflammatory landscape in glioblastoma-bearing mice.
    Soubéran A; Brustlein S; Gouarné C; Chasson L; Tchoghandjian A; Malissen M; Rougon G
    J Neuroinflammation; 2019 Oct; 16(1):191. PubMed ID: 31660979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Insights into Mesenchymal Signatures in Glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Date I
    Acta Med Okayama; 2022 Oct; 76(5):489-502. PubMed ID: 36352795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
    Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.
    Stafford JH; Hirai T; Deng L; Chernikova SB; Urata K; West BL; Brown JM
    Neuro Oncol; 2016 Jun; 18(6):797-806. PubMed ID: 26538619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered exosomes targeting MYC reverse the proneural-mesenchymal transition and extend survival of glioblastoma.
    Haltom AR; Hassen WE; Hensel J; Kim J; Sugimoto H; Li B; McAndrews KM; Conner MR; Kirtley ML; Luo X; Xie B; Volpert OV; Olalekan S; Maltsev N; Basu A; LeBleu VS; Kalluri R
    Extracell Vesicle; 2022 Dec; 1():. PubMed ID: 37503329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.
    Gressot LV; Doucette TA; Yang Y; Fuller GN; Heimberger AB; Bögler O; Rao A; Latha K; Rao G
    Int J Cancer; 2015 May; 136(9):2047-54. PubMed ID: 25302990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLK3 promotes the proneural-mesenchymal transition in glioblastoma via transcriptional regulation of C5AR1.
    Yu S; Lv L; Li Y; Ning Q; Liu T; Hu T
    Mol Biol Rep; 2023 Oct; 50(10):8249-8258. PubMed ID: 37568042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma.
    Ozawa T; Riester M; Cheng YK; Huse JT; Squatrito M; Helmy K; Charles N; Michor F; Holland EC
    Cancer Cell; 2014 Aug; 26(2):288-300. PubMed ID: 25117714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor progression is independent of tumor-associated macrophages in cell lineage-based mouse models of glioblastoma.
    Chipman ME; Wang Z; Sun D; Pedraza AM; Bale TA; Parada LF
    Proc Natl Acad Sci U S A; 2023 Apr; 120(16):e2222084120. PubMed ID: 37040416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.